GlobalData
GlobalData

Beth

Investment in electricity network expansion crucial for Argentina to avoid another power disruption

Following the massive power disruption that crippled the Argentinian power systems, Ankit Mathur, Practice Head of Power at GlobalData, a leading data and analytics company, offers his view on Argentina’s power industry: “The power outage uncovered the decrepit state of power infrastructure in Argentina and with an increasing population and urbanization the power demand is […]
Read more

UK shoppers set to spend £653m on Father’s Day this year

Father’s Day spend is forecast to reach £635m in 2019, less than half of the amount spent on Mother’s Day but this occasion will experience higher growth than its more popular female counterpart, with spend set to rise by 1.0% (equating to £6.2m), according to GlobalData, a leading data and analytics company. With all retail […]
Read more

Global smart meters market set to reach US$7.06bn in 2023

The global smart meters market is estimated to be worth US$7.06bn in 2023, increasing from US$5.8bn in 2018, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘Smart Meters, Update 2019 – Global Market Size, Competitive Landscape and Key Country Analysis to 2023’ reveals that this growth will be driven by evolving information […]
Read more

Spending on automated home devices to hit $75bn by 2025

Global spending on automated home devices is expected to reach $75bn by 2025, up from $23bn in 2018, according to GlobalData, a leading data and analytics company. According to the company’s latest report ‘Thematic Research: Automated home’, much of that growth will be driven by two types of devices: smart thermostats, which are becoming increasingly common as […]
Read more

Roche’s Xofluza shows promise in flu prevention

Following the recent news that Roche’s Phase III influenza drug Xofluza met its primary endpoint for influenza prevention, Philipp Rosenbaum, Pharma Analyst at GlobalData, a leading data and analytics company, offers his perspective: “Given that seasonal influenza vaccines were only around 45% effective over the past 10 influenza seasons, a prophylactic label expansion for Xofluza could […]
Read more

Novavax’s ResVax at risk of losing first-to-market lead in RSV vaccines

Following the recent news that the FDA has recommended an additional Phase III trial for Novavax’s vaccine to prevent medically significant RSV disease in infants, Paul Jeng, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his perspective: “After a string of late-stage clinical disappointments in trials of both elderly adults and pregnant […]
Read more

Amazon to account for one fifth of UK online spend by 2024

Amazon is set to continue experiencing exponential growth with UK retail revenue set to rise 58.2% over the next five years to reach £15.7bn by 2024, according to GlobalData, a leading data and analytics company.  GlobalData’s report: ‘Amazon Strategic Review – 2019’ reveals that the food & grocery sector is anticipated to be the largest […]
Read more
1 80 81 82 83 84 93